There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

What about Saphris (asenapine)?

In this episode of Pearls & Prep, we break down one of the more overlooked second-generation antipsychotics and explore where asenapine may fit in the treatment of bipolar I disorder, acute mania, mixed episodes, and schizophrenia.

We’ll cover why Saphris is given sublingually, what makes its receptor profile unusual, and how its strong dopamine D2, serotonin 5-HT2A/5-HT2C, histamine H1, and adrenergic activity translates into clinical practice.

We’ll also tackle an important bipolar pearl: Saphris can be used for bipolar I maintenance even though it is not an established treatment for acute bipolar depression.

You'll learn:

• Who may be a good candidate for Saphris

• When you might choose asenapine for acute mania or mixed symptoms

• Why Saphris must dissolve under the tongue

• Why mouth numbness and altered taste occur

• How Saphris affects sleep and sedation

• Weight and metabolic considerations

• Why its low muscarinic activity matters

• How 5-HT2A, 5-HT2C, H1, D2 and α-adrenergic receptors matter clinically

• The surprising pharmacologic similarities—and major differences—between Saphris and Remeron

• When Saphris may NOT be the antipsychotic you want

Perfect for PMHNP students, psychiatric nurse practitioners, psychiatry residents, prescribers, and clinicians studying psychopharmacology, bipolar disorder, schizophrenia, antipsychotics, or psychiatric medications.

Key medications discussed: Saphris (asenapine), Zyprexa (olanzapine), Seroquel (quetiapine), Abilify (aripiprazole), Remeron (mirtazapine), risperidone, and paliperidone.

Pearls & Prep — your preceptor in your pocket.

36

Saphris Made Easy: Why Choose Asenapine Over Other Antipsychotics?

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Wellbutrin vs. Trintellix: When SSRIs Help but Something's Still Missing

Your patient's depression is improving. They're less anxious, less tearful, and less reactive. But there's a problem: they still can't feel much joy, struggle with motivation, or complain that their emotions feel flat.

Is this residual depression, SSRI-induced emotional blunting, or both? And should you consider Wellbutrin or Trintellix?

In this episode of Pearls & Prep, NPZ breaks down two unique antidepressants—Wellbutrin (bupropion) and Trintellix (vortioxetine)—and explores how psychiatric nurse practitioners can think through these common prescribing dilemmas.

We'll discuss:

• Wellbutrin vs. Trintellix: How their mechanisms of action differ.
• SSRI emotional blunting: Why patients may feel less sadness but also less joy.
• Dopamine and serotonin: How these neurotransmitter systems influence reward, motivation, and emotional processing.
• When to consider Wellbutrin: Low energy, poor motivation, sexual side effects, and residual depressive symptoms.
• When to consider Trintellix: Depression with cognitive complaints, SSRI tolerability problems, and situations where a serotonergic approach remains desirable.
• Switching vs. augmentation: Why an effective SSRI shouldn't automatically be abandoned.
• Clinical precautions: Seizure risk, nausea, medication interactions, and practical prescribing considerations.

This isn't another dry psychopharmacology lecture. It's a real-world conversation about matching antidepressants to patients rather than simply treating a diagnosis.

Whether you're a psychiatric mental health nurse practitioner (PMHNP), NP student, or new psychiatric prescriber, this episode will help sharpen your clinical reasoning around antidepressant selection.

Want access to the full teaching library + my 100 Psychiatric Interview Tips eBook? Join Boss Pearl.

Want direct feedback? Join Mafia Pearl—I’ll work with you through live mock-patient cases and give you personalized feedback.

Join us: https://www.patreon.com/PearlsAndPrep

Pearls & Prep: Your preceptor in your pocket.

#PsychiatricNursePractitioner #PMHNP #Psychopharmacology #Wellbutrin #Trintellix #Antidepressants #MentalHealth

42

Wellbutrin vs. Trintellix: Dopamine Boost or Serotonin Fine-Tuning When SSRIs Fail?

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Vraylar vs Abilify: what’s the actual difference—and when would a psychiatric provider choose one over the other?

In this episode of Pearls and Prep, NPZ breaks down cariprazine (Vraylar) vs aripiprazole (Abilify) in a practical, easy-to-remember comparison for psychiatric nurse practitioner students, new grad PMHNPs, and mental health clinicians.

We cover the FDA indications that separate these medications, including schizophrenia, bipolar I disorder, major depressive disorder augmentation, bipolar depression, irritability associated with autism, and Tourette’s disorder. Then we go deeper into the psychopharmacology: D2 vs D3 partial agonism, why Vraylar’s D3 activity matters when thinking about motivation and negative symptoms, and how serotonin receptors fit into the picture.

You’ll also learn why bipolar depression is such an important distinction between these medications, why Abilify’s long-acting injectable formulations can completely change the decision for a patient struggling with adherence, and how akathisia may show up simply as a patient telling you, “This medication is making me incredibly anxious.”

And then there’s the real-world issue that can override everything else: access and cost.

By the end, you’ll have a much clearer framework for thinking through Vraylar vs Abilify—not just memorizing two medication profiles, but understanding how FDA indications, receptors, side effects, adherence, cost, and the patient sitting in front of you all influence the decision.

🎧 Topics include: Vraylar vs Abilify, cariprazine vs aripiprazole, bipolar I depression, bipolar mania, schizophrenia, negative symptoms, D2 and D3 receptors, partial dopamine agonists, MDD augmentation, akathisia, antipsychotic side effects, LAI antipsychotics, autism irritability, and psychopharmacology for PMHNP students.

Want the full teaching library + my 100 Psychiatric Interview Tips eBook? Join Boss Pearl at Patreon.com/PearlsAndPrep.

Educational content only. This podcast does not provide individualized medical advice.

35

Vraylar vs Abilify: What’s the Actual Difference? D2, D3 & Beyond

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

A patient has panic attacks, avoids driving, and recently witnessed a traumatic accident. PTSD seems obvious—but is it?

In this psychiatric case study, we break down panic disorder vs PTSD and explore why these diagnoses can look remarkably similar in clinical practice. You’ll learn how to distinguish trauma-related avoidance from fear of another panic attack, identify what the patient’s intrusive experiences are actually about, and uncover the “center of gravity” of the patient’s distress.

Perfect for PMHNP students, psychiatric nurse practitioners, psychiatry students, and mental health clinicians, this episode offers practical interviewing pearls for navigating ambiguous presentations without being led astray by a dramatic trauma history.

Pearls covered: panic disorder, panic attacks, PTSD, trauma, avoidance, intrusive symptoms, differential diagnosis, DSM-5-TR reasoning, psychiatric assessment, and high-yield clinical interviewing.

34

Panic Disorder vs PTSD: How to Tell the Difference

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Schizoid or Schizotypal? They Look Alike—Until You Ask WHY

Schizoid and schizotypal personality disorder sound alike—and both patients may appear socially isolated, detached, or eccentric—but the reason WHY they withdraw can be completely different.

In this episode of Pearls and Prep, NPZ breaks down schizoid vs schizotypal personality disorder using practical outpatient clues: what these patients may actually say in your office, why they avoid relationships, how their social histories differ, and what to listen for when exploring suspiciousness, ideas of reference, magical thinking, unusual beliefs, and restricted affect.

We also tackle the differentials that can trip clinicians up: schizophrenia and psychosis, autism spectrum disorder, depression, social anxiety, and avoidant personality disorder.

The big pearl: don't just notice that your patient is isolated—figure out WHY they're isolated. That distinction can completely change your diagnostic formulation.

🎧 Your preceptor in your pocket: practical psychiatric pearls that prep you to practice.

33

Schizoid or Schizotypal? The Clinical Clues That Give It Away

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Why I Have a Love-Hate Relationship with Latuda

Latuda (lurasidone) is one of the most unique medications in psychiatry—but it's also one of the easiest to misunderstand.

In this episode of Pearls & Prep, we break down exactly when Latuda shines, where it falls short, and how experienced clinicians think through prescribing it in real practice.

You'll learn:

• Why Latuda is FDA-approved for bipolar I depression and schizophrenia

• Why it treats depression but isn't your best option for mania prevention

• How Latuda compares with Seroquel, Abilify, Lamictal, lithium, and Symbyax

• The importance of treating both poles of bipolar disorder—not just today's symptoms

• The famous 350-calorie food requirement and why it matters clinically

• Why Latuda is considered one of the more weight-neutral antipsychotics

• Common adverse effects including akathisia, nausea, and movement disorders

• Practical prescribing pearls you'll actually remember during patient care

Whether you're a PMHNP student, psychiatric NP, psychiatry resident, physician assistant, medical student, or practicing clinician, this episode focuses on the clinical reasoning behind medication selection—not just memorizing facts.

If you're preparing for boards or simply want to become more confident prescribing psychiatric medications, this episode is packed with practical psychopharmacology pearls.

32

Why I Have a Love-Hate Relationship with Latuda

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

We’re diving deep into the showdown of the century: Cymbalta vs. Effexor! This isn’t just another med comparison; we’re talking about the nitty-gritty of which one might actually be a better fit for your patients based on their unique circumstances. Just like the classic debates over LeBron vs. MJ, or Yankees vs. Red Sox, it’s all about context here. If you've got a patient battling chronic pain, Cymbalta is often the MVP, but throw in social anxiety and Effexor might steal the spotlight. We’ll break down the ins and outs of these meds, so you can have the knowledge to back up your prescribing game and make your patients feel empowered. Trust me, this is the kind of talk that'll level up your clinical skills!

31

Inside the Ring 🥊: Effexor or Cymbalta? Here’s the Real Difference

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Diving into the juicy details of Cymbalta versus Effexor, we tackle the age-old debate of which med comes out on top. It’s not just about who wears the crown; it’s about the context, baby! Our chat kicks off with a rundown of each medication’s strengths. If your patient is wrestling with chronic pain, Cymbalta is like a heavyweight champ, knocking out discomfort in conditions like fibromyalgia and diabetic neuropathy.

But wait—if social anxiety or panic is more their jam, Effexor might take the lead with its FDA approval for those specific issues. Just like comparing LeBron to MJ, it’s all about the situation at hand! We explore the nitty-gritty of psychopharmacology, empowering folks to make informed decisions when prescribing. As we roll along, we get into the weeds of how these meds actually work. The conversation takes a turn towards the complexities of FDA approvals and manufacturer motivations. It turns out, Cymbalta was all about pain trials, while Effexor was strutting its stuff in the anxiety arena. But here’s the kicker: just because Cymbalta isn’t FDA-approved for social anxiety doesn’t mean it’s a slouch in that department.

We’re here to remind you that real-life practice doesn’t always align with textbook rules. Every patient is a unique puzzle, and understanding their pain versus anxiety levels can make all the difference in choosing the right med. Wrapping it up, we emphasize the importance of patient context and the subtleties that can sway a prescribing decision. We touch on the potential for side effects, protein binding quirks, and the unpredictable nature of drug interactions. It’s a rollercoaster of insights that leaves us with a reminder: there’s no one-size-fits-all answer—just like in life, it’s about finding what fits best for each individual. Tune in for a smart and sassy breakdown of the meds that can change lives!

Takeaways:

• Cymbalta is a solid choice for patients with chronic pain, like fibromyalgia, while Effexor shines brighter for anxiety disorders.
• Understanding the context of a patient's condition is crucial when choosing between Cymbalta and Effexor; it's not one-size-fits-all.
• Both Cymbalta and Effexor have unique properties that make them effective, but their indications can vary based on individual patient needs.
• Medication interactions are a big deal; if your patient is on multiple drugs, keeping an eye on protein binding is super important for safety.

Companies mentioned in this episode:

• Cymbalta
• Effexor

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Want to feel more confident interviewing psychiatric patients? In this episode of Pearls and Prep, NPZ shares 4 psychiatric interview skills every new PMHNP needs to conduct smoother, more organized, and more human psychiatric evaluations.

Learn how to use a structured psychiatric intake, build genuine therapeutic rapport, recognize important clinical clues, ask better follow-up questions, and develop a repeatable system that keeps your evaluation on track.

You’ll also learn two memorable interviewing techniques: the “life raft” approach for helping patients feel genuinely heard and the “squeeze the orange” technique for recognizing and exploring the valuable diagnostic clues patients drop during their stories.

Whether you're a PMHNP student, new psychiatric nurse practitioner, or new mental health provider, these practical psychiatric evaluation tips will help you ask better questions, improve your clinical interviewing skills, and walk into your next patient encounter with more confidence.

🎧 Pearls and Prep: Your preceptor in your pocket.

Topics: psychiatric interview skills, psychiatric evaluation, PMHNP, PMHNP student, psychiatric assessment, mental health assessment, psychiatric intake, new grad PMHNP, clinical interviewing, therapeutic rapport

34

How to Interview Psychiatric Patients With Confidence: 4 Skills Every New PMHNP Needs

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink